Aytu BioScience, which specializes in innovative urology wellness treatments, recently announced the appointment of experienced financial operations professional David Green to become its new chief financial officer at its Englewood, Colorado hub.

Green will be tasked to direct the company’s financial and accounting work, reporting to CEO Josh Disbrow. A Certified Public Accountant, he earned a bachelor’s degree from the State University of New York and an MBA from the University of Rochester.

"Dave's deep experience in finance, accounting and operations at high-growth, commercial-stage life sciences companies, along with his extensive transactional, valuation, and strategic planning expertise make him an excellent addition to Aytu's senior leadership team at this important stage of the company's growth," Disbrow said. "Dave's extensive background … will be valuable to Aytu as we continue to grow….”

Before joining Aytu, Green served in leadership roles at several bioscience firms: Intarcia Therapeutics, Catheter Connections, and Specialized Health Products International. He also worked at global investment banking firms.

"I am excited to be joining Josh and his talented leadership team at Aytu, and believe the Company is well positioned for tremendous value creation as we continue toward our objective of building a leading specialty life sciences company with substantial prospects for growth," Green said.  

Aytu BioScience specializes in marketing urology products for sexual and reproductive health, with two products currently available by prescription.